Inhibition of DDR1 enhances in vivo chemosensitivity in KRAS-mutant lung adenocarcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inhibition of DDR1 enhances in vivo chemosensitivity in KRAS-mutant lung adenocarcinoma

Published:2020-08-06 Issue:15 Volume:5 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Nokin Marie-Julie,Darbo Elodie^ORCID,Travert Camille^ORCID,Drogat Benjamin^ORCID,Lacouture Aurélie,San José Sonia,Cabrera Nuria,Turcq Béatrice^ORCID,Prouzet-Mauleon Valérie,Falcone Mattia^ORCID,Villanueva Alberto,Wang Haiyun^ORCID,Herfs Michael,Mosteiro Miguel,Jänne Pasi A.,Pujol Jean-Louis,Maraver Antonio^ORCID,Barbacid Mariano,Nadal Ernest^ORCID,Santamaría David^ORCID,Ambrogio Chiara^ORCID

Funder

Fondation ARC pour la recherche contre le cancer

Region Nouvelle Aquitaine

Siric-BRIO

Giovanni Armenise–Harvard Foundation

Lung Cancer Research Foundation

Spanish Association Against Cancer

Bourse d’excellence de la Fédération Wallonie-Bruxelles

Acció instrumental d’intensificació de professionals de la salut

CERCA Program / Generalitat de Catalunya

Senior Chair Idex-Université de Bordeaux

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/137869/files/pdf

Reference50 articles.

1. Global cancer statistics, 2012

2. KRAS Mutations in Lung Cancer

3. K-ras oncogene silencing strategy reduces tumor growth and enhances gemcitabine chemotherapy efficacy for pancreatic cancer treatment

4. KRAS Mutation: Should We Test for It, and Does It Matter?

5. KRAS mutations affect prognosis of non-small-cell lung cancer patients treated with first-line platinum containing chemotherapy

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vivo vulnerabilities to GPX4 and HDAC inhibitors in drug-persistent versus drug-resistant BRAFV600E lung adenocarcinoma;Cell Reports Medicine;2024-08

2. Cirrhotic-extracellular matrix attenuates aPD-1 treatment response by initiating immunosuppressive neutrophil extracellular traps formation in hepatocellular carcinoma;Experimental Hematology & Oncology;2024-02-22

3. Discoidin domain receptor 1 as a potent therapeutic target in solid tumors;hLife;2024-01

4. Altered Treg Infiltration after Discoidin Domain Receptor 1 (DDR1) Inhibition and Knockout Promotes Tumor Growth in Lung Adenocarcinoma;Cancers;2023-12-08

5. Discoidin Domain Receptor Tyrosine Kinase 1 (DDR1) Is a Novel Therapeutic Target in Liposarcoma: A Tissue Microarray Study;Clinical Orthopaedics & Related Research;2023-09-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3